Skip to main content
Swing Capital

TTK Healthcare Ltd

NSE: TTKHLTCARE BSE: 507747Healthcare

TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. [1] It is a part of TT Krishnamachari group; whose flagship company, TTK Prestige Ltd is one of the leading kitchen appliances company in India.[2]

₹889
52W: ₹735 — ₹1402
PE 18 · Book ₹768 · +16% vs book
Market Cap₹1,256 Cr
Stock P/E18Price to Earnings
ROCE9.26%Return on Capital
ROE6.89%Return on Equity
Div. Yield1.11%Face Value ₹10

Strengths

  • +Company is almost debt free.
  • +Stock is trading at 1.17 times its book value
  • +Company has delivered good profit growth of 42.0% CAGR over last 5 years
  • +Company has a good return on equity (ROE) track record: 3 Years ROE 29.2%

Weaknesses

  • −The company has delivered a poor sales growth of 4.42% over past five years.
  • −Earnings include an other income of Rs.59.6 Cr.

Shareholding Pattern

Promoters74.57%
FIIs1.9%
DIIs1.11%
Public22.43%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters74.57%74.57%74.57%74.57%74.57%74.57%74.57%74.57%
FIIs1.87%1.9%▲0.01.9%1.9%1.89%▼0.01.9%▲0.01.89%▼0.01.9%▲0.0
DIIs1.14%1.14%1.14%1.14%1.18%▲0.01.18%1.08%▼0.11.11%▲0.0
Public22.44%22.39%▼0.122.39%22.4%▲0.022.37%▼0.022.37%22.46%▲0.122.43%▼0.0

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales186184181208198205190226204209
Expenses176179169201190197178224198202
Operating Profit1051278812357
OPM %5%3%7%3%4%4%6%1%3%3%
Net Profit16131832171716132011
EPS ₹11.339.1212.9322.3512.1711.8411.439.214.437.45

AI Insights

Revenue Trend

TTM revenue at ₹830Cr, up 3.6% YoY. OPM at 3%.

Debt Position

Borrowings at ₹27Cr. Debt-to-equity ratio: 0.03x. Healthy balance sheet.

Institutional Flow

DIIs: 1.11% (-2.16pp change). FIIs: 1.9% (-0.50pp change). Promoters hold 74.57%.

Margin & Efficiency

ROCE declining from 17% (Mar 2014) to 9% (Mar 2025). Working capital days: 48.

Valuation

PE 18x with 9.26% ROCE. Price is 16% above book value of ₹768. Dividend yield: 1.11%.

Recent Announcements